CANDIDO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 8.309
AS - Asia 6.263
EU - Europa 4.255
SA - Sud America 872
AF - Africa 186
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 14
Totale 19.939
Nazione #
US - Stati Uniti d'America 8.079
SG - Singapore 2.040
CN - Cina 1.335
IT - Italia 1.054
HK - Hong Kong 727
PL - Polonia 712
BR - Brasile 635
KR - Corea 554
VN - Vietnam 538
SE - Svezia 419
UA - Ucraina 311
FR - Francia 300
BD - Bangladesh 290
FI - Finlandia 264
DE - Germania 238
GB - Regno Unito 224
NL - Olanda 186
IN - India 172
RU - Federazione Russa 167
TR - Turchia 136
MX - Messico 91
CA - Canada 88
BG - Bulgaria 73
MA - Marocco 71
AR - Argentina 67
JP - Giappone 64
IE - Irlanda 62
ID - Indonesia 57
ES - Italia 55
PK - Pakistan 43
CO - Colombia 42
AT - Austria 38
EC - Ecuador 38
PH - Filippine 35
IQ - Iraq 34
TW - Taiwan 33
AU - Australia 31
PE - Perù 29
ZA - Sudafrica 28
EG - Egitto 24
BE - Belgio 23
SA - Arabia Saudita 22
CH - Svizzera 20
CL - Cile 20
IL - Israele 19
TH - Thailandia 19
IR - Iran 18
HR - Croazia 16
TN - Tunisia 16
CZ - Repubblica Ceca 15
NP - Nepal 15
PY - Paraguay 15
VE - Venezuela 15
SN - Senegal 14
AZ - Azerbaigian 13
GR - Grecia 13
LB - Libano 13
MY - Malesia 13
JO - Giordania 12
UZ - Uzbekistan 12
EU - Europa 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
DK - Danimarca 8
NI - Nicaragua 8
NZ - Nuova Zelanda 8
RS - Serbia 8
KE - Kenya 7
KZ - Kazakistan 7
PT - Portogallo 7
AL - Albania 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
JM - Giamaica 6
LT - Lituania 6
RO - Romania 6
TT - Trinidad e Tobago 6
CY - Cipro 5
HN - Honduras 5
UY - Uruguay 5
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
LU - Lussemburgo 4
PA - Panama 4
PS - Palestinian Territory 4
AM - Armenia 3
BB - Barbados 3
LK - Sri Lanka 3
LV - Lettonia 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
GE - Georgia 2
GT - Guatemala 2
Totale 19.903
Città #
Singapore 1.163
Ashburn 915
Hong Kong 715
Woodbridge 700
Ann Arbor 624
San Jose 613
Warsaw 593
Houston 581
Fairfield 527
Seoul 526
Chandler 412
Hefei 360
Boardman 294
Seattle 266
Jacksonville 261
Beijing 254
Wilmington 244
Ho Chi Minh City 183
Cambridge 176
Los Angeles 142
Milan 142
Trieste 142
Helsinki 139
Chicago 132
Hanoi 125
Council Bluffs 106
Lauterbourg 99
Princeton 98
Zgierz 98
The Dalles 93
Izmir 90
Columbus 86
Dallas 77
Moscow 77
New York 75
London 73
Frankfurt am Main 69
Buffalo 67
Santa Clara 64
Casablanca 63
São Paulo 63
Sofia 62
Dublin 58
Rome 55
Tokyo 43
Shanghai 42
Düsseldorf 41
Dearborn 40
Nuremberg 39
Munich 37
Orem 31
San Diego 31
Chennai 30
Atlanta 26
Mumbai 26
Boston 23
Brussels 23
Haiphong 23
Jinan 23
Naples 23
Phoenix 23
Guangzhou 22
Miano 22
Hangzhou 21
Montreal 21
Toronto 21
Zhengzhou 21
Brooklyn 20
Memphis 20
Rio de Janeiro 20
Manchester 19
Redondo Beach 19
Chengdu 18
Da Nang 18
Dhaka 18
Lappeenranta 18
Stockholm 18
Turku 18
Washington 18
Baghdad 17
Verona 17
Vienna 17
Bari 16
Cairo 16
Denver 16
Mexico City 16
Venice 16
Istanbul 15
Amsterdam 14
Johannesburg 14
Karachi 14
Quito 14
Tianjin 14
Ankara 13
Dakar 13
Falls Church 13
Jakarta 13
Santiago 13
Segrate 13
Amman 12
Totale 12.884
Nome #
A new ultrasonographic instrument for measuring vessel wall shear stress. 478
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 426
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 414
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events 359
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 346
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 343
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 306
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 295
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. 285
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 274
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 273
DOSE AND TIME-DEPENDENT APOPTOTIC EFFECTS BY ANGIOTENSIN II INFUSION ON LEFT VENTRICULAR CARDIOMYOCYTES. 262
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 260
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 251
ACE2 deficiency shifts energy metabolism towards glucose utilization 243
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 236
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 230
Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials 228
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 226
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 225
TRAIL shows potential cardioprotective activity. 221
Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm 220
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 219
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 217
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 210
Haemoconcentration, shear-stress elevation and carotid artery diameter regulation after furosemide in older hypertensives 208
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 206
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 203
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 203
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 199
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension 198
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 184
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 183
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB 183
Comparative effects of antihypertensive and/or antioxidative treatment in an experimental model of chronic progressive nephrosis 181
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 180
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents 179
Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: a retrospective cohort study 176
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 176
Endothelial dysfunction (ED) in familial hypercholesterolemia (FH). Role of the LDL-cholesterol (LDL) variations after LDL-aphaeresis (LDL-A) vs medical therapy 174
Angiotensin II promotes apoptosis in ventricular cardiomyoctes in vivo 174
Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group 169
Modulation of cardiac apoptosis by estrogen and ACE inhibition in ovariectomized spontaneously hypertensive rats 167
In vivo effects of fluvastatin on leukocyte vascular trafficking under experimental acute inflammatory conditions 163
Hypertension and diabetes: emphasis on the renin-angiotensin system in atherosclerosis 163
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 158
Regional and systemic haemodynamic response to aortography in hypertensives. 155
Italian guidelines for the treatment of type 2 diabetes 154
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 150
Linking diabetes and atherosclerosis 148
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials. 142
Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression 142
Endothelium vasomotor function after LDL-apheresis in patients with familial hypercolesterolemia 141
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 140
Retrospective cohort study on treatment outcomes of early vs late onset gestational diabetes mellitus 139
Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells 135
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study 132
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience 126
Profiles of sulfonylurea use in Diabetes Mellitus type 2: an analysis of clinical practice over the last 10 years 126
Forearm endothelial dysfuncion (ED) is a marker of the epato-renal vascular impairment but not of the systemic haemodynamic control in cirrhotic patients 126
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study 125
Treatment for diabetic nephropathy - a review of the recent patent literature 125
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice 124
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive doses of an ACE inhibitor 123
Safety and Appropriateness in the Management of the Treatment Pathway of Pregnant Women with Gestational Diabetes 121
A review of the latest real‐world evidence studies in diabetic kidney disease: What have we learned about clinical practice and the clinical effectiveness of interventions? 121
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 120
Large artery mechanics after bladder neck obstruction in SHR rats 120
Personalized Approach for the Management of Exercise-Related Glycemic Imbalances in Type 1 Diabetes: Comparison with Reference Method 120
Modulation of glomerular albumin permeability by angiotensin II infusion and effects of angiotensin type 1 receptor blockade 117
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 112
The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals initiative 112
2023 update on Italian guidelines for the treatment of type 2 diabetes 111
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes 109
La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti 108
A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy 108
Sinergia collaborativa nella gestione del paziente diabetico con recente sindrome coronarica acuta 101
Temporal trends in the starting of insulin therapy in type 2 diabetes in Italy: data from the AMD Annals initiative 100
The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care 99
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products 98
Open questions on basal insulin therapy in T2D: a Delphi consensus 98
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 97
Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes 96
ACE-inhibitor treatment prevents cardiac remodelling in experimental uremia 96
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 96
Lipid-lowering therapy and LDL target attainment in type 2 diabetes: trends from the Italian Associations of Medical Diabetologists database 95
Type 2 diabetes specialist care in Italy in the AMD Annals initiative 2024: The path is traced 94
Prevalence and clinical determinants of rapid eGFR decline among patients with newly diagnosed type 2 diabetes 93
Ace Inhibitor treatment prevents renal growth and hyperfiltration in streptozotocin diabetic rats 91
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 91
Exploring the benefits of alirocumab as lipid-lowering therapy in people with diabetes and very high cardiovascular risk 89
Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform 89
Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications 87
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group 87
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study 84
ACE inhibitor treatment prevents cardiac programmed cell death and intermyocardiocytic fibrosis in hypertensive diabetic rats 82
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies 82
Socioeconomic and health disparities in adults diagnosed with type 1 diabetes mellitus before age 18: insights from the Italian PASSI surveillance system 82
When does metabolic memory start? Insights from the AMD Annals Initiative on stringent HbA1c targets 81
A new ultrasonographic instrument for measuring vessel wall shear stress: Comparison to a mathematical model in essential hypertensives 80
Totale 16.894
Categoria #
all - tutte 61.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/2022631 24 36 24 58 21 57 32 17 71 67 54 170
2022/20231.120 87 126 99 146 113 207 3 108 155 15 46 15
2023/20241.332 47 233 74 57 109 86 201 148 23 27 157 170
2024/20253.585 128 125 206 240 527 464 305 203 389 434 261 303
2025/20268.696 636 568 570 839 610 704 1.010 363 984 1.332 646 434
Totale 20.402